Publisher： John Wiley & Sons Inc
E-ISSN： 2050-0904|3|7|638-642
ISSN： 2050-0904
Source： Clinical Case Reports, Vol.3, Iss.7, 2015-07, pp. : 638-642
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Spotlight on Insulin Detemir in Type 1 and 2 Diabetes Mellitus
By Chapman Therese M. Perry Caroline M.
BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. :
Access to resources
Recommend
Long-Acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus
By Vilsbøll Tina Knop Filip K.
BioDrugs, Vol. 22, Iss. 4, 2008-01 ,pp. :
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus: Potential for Immunotherapy
BioDrugs, Vol. 15, Iss. 5, 2001-05 ,pp. :
Prevention Strategies for Type 1 Diabetes Mellitus: Current Status and Future Directions
By Winter W.E.
BioDrugs, Vol. 17, Iss. 1, 2003-01 ,pp. :